使い捨て内視鏡の市場規模、シェア、動向分析レポート:タイプ別(腹腔鏡、関節鏡)、エンドユース別(病院、外来施設)、地域別、セグメント別予測、2024年~2030年Disposable Endoscopes Market Size, Share & Trends Analysis Report By Type (Laparoscopes, Arthroscopes), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2024 - 2030 使い捨て内視鏡市場の成長と動向 Grand View Research, Incの最新レポートによると、世界の使い捨て内視鏡市場規模は2030年までに73億2000万米ドルに達すると予測され、2024年から2030年までのCAGRは17.0%で... もっと見る
1~3営業日
サマリー使い捨て内視鏡市場の成長と動向Grand View Research, Incの最新レポートによると、世界の使い捨て内視鏡市場規模は2030年までに73億2000万米ドルに達すると予測され、2024年から2030年までのCAGRは17.0%で成長すると予測されている。デバイス関連の感染リスクを排除するためのシングルユース内視鏡に対する需要の高まりは、世界市場の成長を促進する主要因である。さらに、低侵襲処置に対する患者の嗜好の高まり、支持的な規制枠組み、先進国における有利な償還政策が市場成長の原動力となっている。さらに、医療インフラの強化や内視鏡検査の研究促進に特化した政府や組織からの投資、資金、助成金の増加が市場成長に寄与している。 汚染された内視鏡が原因で院内感染の発生率が増加しており、これが市場における使い捨て内視鏡の需要を促進する主な要因となっている。American Journal of Infection Control誌によると、2018年3月、内視鏡の49%近くが再処理中に水分を保持していた。また、内視鏡サンプルからは71%の微生物増殖が検出され、患者の感染リスクを高めている。再利用可能な内視鏡は、使用中に微生物、血液、体内分泌物から汚染されるリスクが高い。これらの感染は主に、内視鏡の再処理の失敗、規制ガイドラインの不遵守、欠陥機器の使用により発生する。 技術の進歩は使い捨て内視鏡機器の分野に大きな影響を与え、技術革新を促進し、患者ケアを向上させた。これらの進歩は、より高度で洗練された使い捨て内視鏡の開発につながり、強化された画像処理能力、改善された操作性、使いやすさを提供している。例えば、高解像度カメラと高度な光学系を統合することで、より鮮明でクリアな画像が得られ、正確な診断と治療に役立っている。 部品の小型化により、より小型で柔軟な内視鏡が誕生し、狭く複雑な解剖学的構造へのアクセスが容易になった。さらに、材料や製造技術の進歩により、費用対効果に優れ、信頼性が高く、患者にとって安全な使い捨て内視鏡器具が製造されるようになった。 さらに、機器関連の感染リスクを排除するための使い捨て内視鏡に対する需要の高まりは、世界市場の成長を促進する重要な要因となっている。さらに、低侵襲処置に対する患者の嗜好の高まり、支持的な規制枠組み、先進国における有利な償還政策が市場を牽引している。さらに、医療インフラを強化し、内視鏡検査の研究を推進するための政府や組織からの投資、資金、助成金の増加が市場成長に寄与している。このような動きは、市場に有利な成長見通しを生み出している。 使い捨て内視鏡市場レポートハイライト - タイプ別では、呼吸器系疾患の負担が大きいこと、疾患診断のための内視鏡検査の採用が多いことから、気管支鏡セグメントが最大の収益シェアを占めている。 - 膀胱鏡セグメントは、イメージング技術の進歩と尿路結石の増加により、最も速いCAGRを記録すると予測されている。 - 医療インフラの整備と低侵襲手技の採用増加により、2023年には外来患者施設が最大市場を占める - アジア太平洋地域は、高い疾病負担の中でエンドユーザーからの需要が高く、市場参入企業による様々な戦略的合意により、予測期間中に最も速いCAGRを示すと予想される。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Segment scope 1.1.2. Regional scope 1.1.3. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis 1.6.1.1. Approach: Commodity flow approach 1.7. Research Assumption 1.8. List of Secondary Sources 1.9. List of Abbreviation 1.10. Objectives 1.10.1. Objective 1 1.10.2. Objective 2 1.10.3. Objective 3 1.10.4. Objective 4 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Competitive Insights Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market 3.2. Market Dynamics 3.2.1. Market driver analysis 3.2.1.1. Increase in incidence of target disease 3.2.1.2. Technological advancements 3.2.1.3. Increased use of disposable endoscopes 3.2.1.4. Increasing trend of minimally invasive procedures 3.2.2. Market restraint analysis 3.2.2.1. Dearth of skilled professional 3.2.2.2. Product recalls and failures 3.3. Penetration & Growth Prospect Mapping 3.4. Mechanical Ventilators: Market Analysis Tools 3.4.1. Industry analysis - Porter’s 3.4.2. PESTEL analysis 3.5. Regulatory Framework Chapter 4. Disposable Endoscopes Market Segment Analysis, By Type 4.1. Definition and Scope 4.2. Type Market Share Analysis, 2023 & 2030 4.3. Segment Dashboard 4.4. Global Disposable Endoscopes Market, By Type, 2016 to 2030 4.5. Market Size & Forecast and Trend Analysis, 2016 to 2030 4.5.1. Laparoscopes 4.5.1.1. Laparoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.2. Arthroscopes 4.5.2.1. Arthroscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.3. Ureteroscopes 4.5.3.1. Ureteroscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.4. Cystoscopes 4.5.4.1. Cystoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.5. Gynecology Endoscopes 4.5.5.1. Gynecology endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.6. Neuroendoscopes 4.5.6.1. Neuroemdoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.7. Bronchoscopes 4.5.7.1. Bronchoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.8. Hysteroscopes 4.5.8.1. Hysteroscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.9. Laryngoscopes 4.5.9.1. Laryngoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.10. Otoscopes 4.5.10.1. Bronchoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.11. Sigmoidoscopes 4.5.11.1. Sigmoidoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.12. Duodenoscopes 4.5.12.1. Duodenoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.13. Nasopharyngoscopes 4.5.13.1. Nasopharyngoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.14. Rhinoscopes 4.5.14.1. Rhonoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.15. Colonoscopes 4.5.15.1. Colonoscopes market estimates and forecast, 2016 - 2030 (USD Million) Chapter 5. Disposable Endoscopes Market Segment Analysis, By End-use, 2016 - 2030 (USD Million) 5.1. Definition and Scope 5.2. Interphase Market Share Analysis, 2023 & 2030 5.3. Segment Dashboard 5.4. Global Disposable Endoscopes Market, By End-use, 2016 to 2030 5.5. Market Size & Forecast and Trend Analysis, 2016 to 2030 5.5.1. Outpatient Facilities 5.5.1.1. Outpatient Facilities market estimates and forecast, 2016 - 2030 (USD Million) 5.5.2. Hospitals 5.5.2.1. Hospitals market estimates and forecast, 2016 - 2030 (USD Million) Chapter 6. Disposable Endoscopes Market Segment Analysis, By Region, 2016 - 2030 (USD Million) 6.1. Definition and Scope 6.2. Regional Market Share Analysis, 2023 & 2030 6.3. Regional Market Dashboard 6.4. Regional Market Snapshot 6.5. SWOT Analysis 6.5.1. North America 6.5.2. Europe 6.5.3. Asia Pacific 6.5.4. Latin America 6.5.5. Middle East & Africa 6.6. Market Size & Forecast, Revenue and Trend Analysis, 2023 to 2030 6.6.1. North America 6.6.1.1. North America disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 6.6.1.2. U.S. 6.6.1.2.1. Key country dynamics 6.6.1.2.2. Competitive scenario 6.6.1.2.3. Regulatory framework 6.6.1.2.4. Reimbursement scenario 6.6.1.2.5. U.S. market estimates and forecast, 2016 - 2030 (USD Million) 6.6.1.3. Canada 6.6.1.3.1. Key country dynamics 6.6.1.3.2. Competitive scenario 6.6.1.3.3. Regulatory framework 6.6.1.3.4. Reimbursement scenario 6.6.1.3.5. Canada market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2. Europe 6.6.2.1. Europe disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.2. UK 6.6.2.2.1. Key country dynamics 6.6.2.2.2. Competitive scenario 6.6.2.2.3. Regulatory framework 6.6.2.2.4. Reimbursement scenario 6.6.2.2.5. UK market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.3. Germany 6.6.2.3.1. Key country dynamics 6.6.2.3.2. Competitive scenario 6.6.2.3.3. Regulatory framework 6.6.2.3.4. Reimbursement scenario 6.6.2.3.5. Germany market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.4. Spain 6.6.2.4.1. Key country dynamics 6.6.2.4.2. Competitive scenario 6.6.2.4.3. Regulatory framework 6.6.2.4.4. Reimbursement scenario 6.6.2.4.5. Spain market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.5. France 6.6.2.5.1. Key country dynamics 6.6.2.5.2. Competitive scenario 6.6.2.5.3. Regulatory framework 6.6.2.5.4. Reimbursement scenario 6.6.2.5.5. France market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.6. Italy 6.6.2.6.1. Key country dynamics 6.6.2.6.2. Competitive scenario 6.6.2.6.3. Regulatory framework 6.6.2.6.4. Reimbursement scenario 6.6.2.6.5. Italy market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.7. Denmark 6.6.2.7.1. Key country dynamics 6.6.2.7.2. Competitive scenario 6.6.2.7.3. Regulatory framework 6.6.2.7.4. Reimbursement scenario 6.6.2.7.5. Denmark market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.8. Norway 6.6.2.8.1. Key country dynamics 6.6.2.8.2. Competitive scenario 6.6.2.8.3. Regulatory framework 6.6.2.8.4. Reimbursement scenario 6.6.2.8.5. Norway market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.9. Sweden 6.6.2.9.1. Key country dynamics 6.6.2.9.2. Competitive scenario 6.6.2.9.3. Regulatory framework 6.6.2.9.4. Reimbursement scenario 6.6.2.9.5. Sweden market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3. Asia Pacific 6.6.3.1. Asia Pacific disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.2. Japan 6.6.3.2.1. Key country dynamics 6.6.3.2.2. Competitive scenario 6.6.3.2.3. Regulatory framework 6.6.3.2.4. Reimbursement scenario 6.6.3.2.5. Japan market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.3. China 6.6.3.3.1. Key country dynamics 6.6.3.3.2. Competitive scenario 6.6.3.3.3. Regulatory framework 6.6.3.3.4. Reimbursement scenario 6.6.3.3.5. China market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.4. India 6.6.3.4.1. Key country dynamics 6.6.3.4.2. Competitive scenario 6.6.3.4.3. Regulatory framework 6.6.3.4.4. Reimbursement scenario 6.6.3.4.5. India market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.5. South Korea 6.6.3.5.1. Key country dynamics 6.6.3.5.2. Competitive scenario 6.6.3.5.3. Regulatory framework 6.6.3.5.4. Reimbursement scenario 6.6.3.5.5. South Korea market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.6. Australia 6.6.3.6.1. Key country dynamics 6.6.3.6.2. Competitive scenario 6.6.3.6.3. Regulatory framework 6.6.3.6.4. Reimbursement scenario 6.6.3.6.5. Australia market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.7. Thailand 6.6.3.7.1. Key country dynamics 6.6.3.7.2. Competitive scenario 6.6.3.7.3. Regulatory framework 6.6.3.7.4. Reimbursement scenario 6.6.3.7.5. Thailand market estimates and forecast, 2016 - 2030 (USD Million) 6.6.4. Latin America 6.6.4.1. Latin America disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 6.6.4.2. Brazil 6.6.4.2.1. Key country dynamics 6.6.4.2.2. Competitive scenario 6.6.4.2.3. Regulatory framework 6.6.4.2.4. Reimbursement scenario 6.6.4.2.5. Brazil market estimates and forecast, 2016 - 2030 (USD Million) 6.6.4.3. Mexico 6.6.4.3.1. Key country dynamics 6.6.4.3.2. Competitive scenario 6.6.4.3.3. Regulatory framework 6.6.4.3.4. Reimbursement scenario 6.6.4.3.5. Mexico market estimates and forecast, 2016 - 2030 (USD Million) 6.6.4.4. Argentina 6.6.4.4.1. Key country dynamics 6.6.4.4.2. Competitive scenario 6.6.4.4.3. Regulatory framework 6.6.4.4.4. Reimbursement scenario 6.6.4.4.5. Argentina market estimates and forecast, 2016 - 2030 (USD Million) 6.6.5. MEA 6.6.5.1. MEA disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 6.6.5.2. South Africa 6.6.5.2.1. Key country dynamics 6.6.5.2.2. Competitive scenario 6.6.5.2.3. Regulatory framework 6.6.5.2.4. Reimbursement scenario 6.6.5.2.5. South Africa market estimates and forecast, 2016 - 2030 (USD Million) 6.6.5.3. Saudi Arabia 6.6.5.3.1. Key country dynamics 6.6.5.3.2. Competitive scenario 6.6.5.3.3. Regulatory framework 6.6.5.3.4. Reimbursement scenario 6.6.5.3.5. Saudi Arabia market estimates and forecast, 2016 - 2030 (USD Million) 6.6.5.4. UAE 6.6.5.4.1. Key country dynamics 6.6.5.4.2. Competitive scenario 6.6.5.4.3. Regulatory framework 6.6.5.4.4. Reimbursement scenario 6.6.5.4.5. UAE market estimates and forecast, 2016 - 2030 (USD Million) Chapter 7. Disposable Endoscopes Market - Competitive Analysis 7.1. Recent Developments & Impact Analysis, by Key Market Participants 7.1.1. Heat map analysis 7.1.2. Major deals and strategic alliances analysis 7.2. Company Categorization 7.2.1. Innovators 7.2.2. Market lenders 7.3. Vendors Landscape 7.3.1. List of key distributors and channel partners 7.3.2. Key customers 7.4. Public Companies 7.4.1. Competitive dashboard analysis 7.4.1.1. Market differentiators 7.5. Private Companies 7.5.1. List of key emerging companies 7.6. Company Profiles 7.6.1. Ambu A/S 7.6.1.1. Company overview 7.6.1.2. Financial performance 7.6.1.3. Product benchmarking 7.6.1.4. Strategic initiative 7.6.2. Boston Scientific Corporation 7.6.2.1. Company overview 7.6.2.2. Financial performance 7.6.2.3. Product benchmarking 7.6.2.4. Strategic initiative 7.6.3. OBP Surgical Corporation 7.6.3.1. Company overview 7.6.3.2. Financial performance 7.6.3.3. Product benchmarking 7.6.3.4. Strategic initiative 7.6.4. Co-opersurgical, Inc. 7.6.4.1. Company overview 7.6.4.2. Financial performance 7.6.4.3. Product benchmarking 7.6.4.4. Strategic initiative 7.6.5. Flexicare Medical Limited 7.6.5.1. Company overview 7.6.5.2. Financial performance 7.6.5.3. Product benchmarking 7.6.5.4. Strategic initiative 7.6.6. Welch Allyn (Hill Rom) 7.6.6.1. Company overview 7.6.6.2. Financial performance 7.6.6.3. Product benchmarking 7.6.6.4. Strategic initiative 7.6.7. HOYA Corporation 7.6.7.1. Company overview 7.6.7.2. Financial performance 7.6.7.3. Product benchmarking 7.6.7.4. Strategic initiative 7.6.8. KARL STORZ 7.6.8.1. Company overview 7.6.8.2. Financial performance 7.6.8.3. Product benchmarking 7.6.8.4. Strategic initiative 7.6.9. Olympus Corporation 7.6.9.1. Company overview 7.6.9.2. Financial performance 7.6.9.3. Product benchmarking 7.6.9.4. Strategic initiative 7.6.10. OTU Medical 7.6.10.1. Company overview 7.6.10.2. Financial performance 7.6.10.3. Product benchmarking 7.6.10.4. Strategic initiatives
SummaryDisposable Endoscopes Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Segment scope 1.1.2. Regional scope 1.1.3. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis 1.6.1.1. Approach: Commodity flow approach 1.7. Research Assumption 1.8. List of Secondary Sources 1.9. List of Abbreviation 1.10. Objectives 1.10.1. Objective 1 1.10.2. Objective 2 1.10.3. Objective 3 1.10.4. Objective 4 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Competitive Insights Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market 3.2. Market Dynamics 3.2.1. Market driver analysis 3.2.1.1. Increase in incidence of target disease 3.2.1.2. Technological advancements 3.2.1.3. Increased use of disposable endoscopes 3.2.1.4. Increasing trend of minimally invasive procedures 3.2.2. Market restraint analysis 3.2.2.1. Dearth of skilled professional 3.2.2.2. Product recalls and failures 3.3. Penetration & Growth Prospect Mapping 3.4. Mechanical Ventilators: Market Analysis Tools 3.4.1. Industry analysis - Porter’s 3.4.2. PESTEL analysis 3.5. Regulatory Framework Chapter 4. Disposable Endoscopes Market Segment Analysis, By Type 4.1. Definition and Scope 4.2. Type Market Share Analysis, 2023 & 2030 4.3. Segment Dashboard 4.4. Global Disposable Endoscopes Market, By Type, 2016 to 2030 4.5. Market Size & Forecast and Trend Analysis, 2016 to 2030 4.5.1. Laparoscopes 4.5.1.1. Laparoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.2. Arthroscopes 4.5.2.1. Arthroscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.3. Ureteroscopes 4.5.3.1. Ureteroscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.4. Cystoscopes 4.5.4.1. Cystoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.5. Gynecology Endoscopes 4.5.5.1. Gynecology endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.6. Neuroendoscopes 4.5.6.1. Neuroemdoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.7. Bronchoscopes 4.5.7.1. Bronchoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.8. Hysteroscopes 4.5.8.1. Hysteroscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.9. Laryngoscopes 4.5.9.1. Laryngoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.10. Otoscopes 4.5.10.1. Bronchoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.11. Sigmoidoscopes 4.5.11.1. Sigmoidoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.12. Duodenoscopes 4.5.12.1. Duodenoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.13. Nasopharyngoscopes 4.5.13.1. Nasopharyngoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.14. Rhinoscopes 4.5.14.1. Rhonoscopes market estimates and forecast, 2016 - 2030 (USD Million) 4.5.15. Colonoscopes 4.5.15.1. Colonoscopes market estimates and forecast, 2016 - 2030 (USD Million) Chapter 5. Disposable Endoscopes Market Segment Analysis, By End-use, 2016 - 2030 (USD Million) 5.1. Definition and Scope 5.2. Interphase Market Share Analysis, 2023 & 2030 5.3. Segment Dashboard 5.4. Global Disposable Endoscopes Market, By End-use, 2016 to 2030 5.5. Market Size & Forecast and Trend Analysis, 2016 to 2030 5.5.1. Outpatient Facilities 5.5.1.1. Outpatient Facilities market estimates and forecast, 2016 - 2030 (USD Million) 5.5.2. Hospitals 5.5.2.1. Hospitals market estimates and forecast, 2016 - 2030 (USD Million) Chapter 6. Disposable Endoscopes Market Segment Analysis, By Region, 2016 - 2030 (USD Million) 6.1. Definition and Scope 6.2. Regional Market Share Analysis, 2023 & 2030 6.3. Regional Market Dashboard 6.4. Regional Market Snapshot 6.5. SWOT Analysis 6.5.1. North America 6.5.2. Europe 6.5.3. Asia Pacific 6.5.4. Latin America 6.5.5. Middle East & Africa 6.6. Market Size & Forecast, Revenue and Trend Analysis, 2023 to 2030 6.6.1. North America 6.6.1.1. North America disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 6.6.1.2. U.S. 6.6.1.2.1. Key country dynamics 6.6.1.2.2. Competitive scenario 6.6.1.2.3. Regulatory framework 6.6.1.2.4. Reimbursement scenario 6.6.1.2.5. U.S. market estimates and forecast, 2016 - 2030 (USD Million) 6.6.1.3. Canada 6.6.1.3.1. Key country dynamics 6.6.1.3.2. Competitive scenario 6.6.1.3.3. Regulatory framework 6.6.1.3.4. Reimbursement scenario 6.6.1.3.5. Canada market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2. Europe 6.6.2.1. Europe disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.2. UK 6.6.2.2.1. Key country dynamics 6.6.2.2.2. Competitive scenario 6.6.2.2.3. Regulatory framework 6.6.2.2.4. Reimbursement scenario 6.6.2.2.5. UK market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.3. Germany 6.6.2.3.1. Key country dynamics 6.6.2.3.2. Competitive scenario 6.6.2.3.3. Regulatory framework 6.6.2.3.4. Reimbursement scenario 6.6.2.3.5. Germany market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.4. Spain 6.6.2.4.1. Key country dynamics 6.6.2.4.2. Competitive scenario 6.6.2.4.3. Regulatory framework 6.6.2.4.4. Reimbursement scenario 6.6.2.4.5. Spain market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.5. France 6.6.2.5.1. Key country dynamics 6.6.2.5.2. Competitive scenario 6.6.2.5.3. Regulatory framework 6.6.2.5.4. Reimbursement scenario 6.6.2.5.5. France market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.6. Italy 6.6.2.6.1. Key country dynamics 6.6.2.6.2. Competitive scenario 6.6.2.6.3. Regulatory framework 6.6.2.6.4. Reimbursement scenario 6.6.2.6.5. Italy market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.7. Denmark 6.6.2.7.1. Key country dynamics 6.6.2.7.2. Competitive scenario 6.6.2.7.3. Regulatory framework 6.6.2.7.4. Reimbursement scenario 6.6.2.7.5. Denmark market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.8. Norway 6.6.2.8.1. Key country dynamics 6.6.2.8.2. Competitive scenario 6.6.2.8.3. Regulatory framework 6.6.2.8.4. Reimbursement scenario 6.6.2.8.5. Norway market estimates and forecast, 2016 - 2030 (USD Million) 6.6.2.9. Sweden 6.6.2.9.1. Key country dynamics 6.6.2.9.2. Competitive scenario 6.6.2.9.3. Regulatory framework 6.6.2.9.4. Reimbursement scenario 6.6.2.9.5. Sweden market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3. Asia Pacific 6.6.3.1. Asia Pacific disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.2. Japan 6.6.3.2.1. Key country dynamics 6.6.3.2.2. Competitive scenario 6.6.3.2.3. Regulatory framework 6.6.3.2.4. Reimbursement scenario 6.6.3.2.5. Japan market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.3. China 6.6.3.3.1. Key country dynamics 6.6.3.3.2. Competitive scenario 6.6.3.3.3. Regulatory framework 6.6.3.3.4. Reimbursement scenario 6.6.3.3.5. China market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.4. India 6.6.3.4.1. Key country dynamics 6.6.3.4.2. Competitive scenario 6.6.3.4.3. Regulatory framework 6.6.3.4.4. Reimbursement scenario 6.6.3.4.5. India market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.5. South Korea 6.6.3.5.1. Key country dynamics 6.6.3.5.2. Competitive scenario 6.6.3.5.3. Regulatory framework 6.6.3.5.4. Reimbursement scenario 6.6.3.5.5. South Korea market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.6. Australia 6.6.3.6.1. Key country dynamics 6.6.3.6.2. Competitive scenario 6.6.3.6.3. Regulatory framework 6.6.3.6.4. Reimbursement scenario 6.6.3.6.5. Australia market estimates and forecast, 2016 - 2030 (USD Million) 6.6.3.7. Thailand 6.6.3.7.1. Key country dynamics 6.6.3.7.2. Competitive scenario 6.6.3.7.3. Regulatory framework 6.6.3.7.4. Reimbursement scenario 6.6.3.7.5. Thailand market estimates and forecast, 2016 - 2030 (USD Million) 6.6.4. Latin America 6.6.4.1. Latin America disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 6.6.4.2. Brazil 6.6.4.2.1. Key country dynamics 6.6.4.2.2. Competitive scenario 6.6.4.2.3. Regulatory framework 6.6.4.2.4. Reimbursement scenario 6.6.4.2.5. Brazil market estimates and forecast, 2016 - 2030 (USD Million) 6.6.4.3. Mexico 6.6.4.3.1. Key country dynamics 6.6.4.3.2. Competitive scenario 6.6.4.3.3. Regulatory framework 6.6.4.3.4. Reimbursement scenario 6.6.4.3.5. Mexico market estimates and forecast, 2016 - 2030 (USD Million) 6.6.4.4. Argentina 6.6.4.4.1. Key country dynamics 6.6.4.4.2. Competitive scenario 6.6.4.4.3. Regulatory framework 6.6.4.4.4. Reimbursement scenario 6.6.4.4.5. Argentina market estimates and forecast, 2016 - 2030 (USD Million) 6.6.5. MEA 6.6.5.1. MEA disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million) 6.6.5.2. South Africa 6.6.5.2.1. Key country dynamics 6.6.5.2.2. Competitive scenario 6.6.5.2.3. Regulatory framework 6.6.5.2.4. Reimbursement scenario 6.6.5.2.5. South Africa market estimates and forecast, 2016 - 2030 (USD Million) 6.6.5.3. Saudi Arabia 6.6.5.3.1. Key country dynamics 6.6.5.3.2. Competitive scenario 6.6.5.3.3. Regulatory framework 6.6.5.3.4. Reimbursement scenario 6.6.5.3.5. Saudi Arabia market estimates and forecast, 2016 - 2030 (USD Million) 6.6.5.4. UAE 6.6.5.4.1. Key country dynamics 6.6.5.4.2. Competitive scenario 6.6.5.4.3. Regulatory framework 6.6.5.4.4. Reimbursement scenario 6.6.5.4.5. UAE market estimates and forecast, 2016 - 2030 (USD Million) Chapter 7. Disposable Endoscopes Market - Competitive Analysis 7.1. Recent Developments & Impact Analysis, by Key Market Participants 7.1.1. Heat map analysis 7.1.2. Major deals and strategic alliances analysis 7.2. Company Categorization 7.2.1. Innovators 7.2.2. Market lenders 7.3. Vendors Landscape 7.3.1. List of key distributors and channel partners 7.3.2. Key customers 7.4. Public Companies 7.4.1. Competitive dashboard analysis 7.4.1.1. Market differentiators 7.5. Private Companies 7.5.1. List of key emerging companies 7.6. Company Profiles 7.6.1. Ambu A/S 7.6.1.1. Company overview 7.6.1.2. Financial performance 7.6.1.3. Product benchmarking 7.6.1.4. Strategic initiative 7.6.2. Boston Scientific Corporation 7.6.2.1. Company overview 7.6.2.2. Financial performance 7.6.2.3. Product benchmarking 7.6.2.4. Strategic initiative 7.6.3. OBP Surgical Corporation 7.6.3.1. Company overview 7.6.3.2. Financial performance 7.6.3.3. Product benchmarking 7.6.3.4. Strategic initiative 7.6.4. Co-opersurgical, Inc. 7.6.4.1. Company overview 7.6.4.2. Financial performance 7.6.4.3. Product benchmarking 7.6.4.4. Strategic initiative 7.6.5. Flexicare Medical Limited 7.6.5.1. Company overview 7.6.5.2. Financial performance 7.6.5.3. Product benchmarking 7.6.5.4. Strategic initiative 7.6.6. Welch Allyn (Hill Rom) 7.6.6.1. Company overview 7.6.6.2. Financial performance 7.6.6.3. Product benchmarking 7.6.6.4. Strategic initiative 7.6.7. HOYA Corporation 7.6.7.1. Company overview 7.6.7.2. Financial performance 7.6.7.3. Product benchmarking 7.6.7.4. Strategic initiative 7.6.8. KARL STORZ 7.6.8.1. Company overview 7.6.8.2. Financial performance 7.6.8.3. Product benchmarking 7.6.8.4. Strategic initiative 7.6.9. Olympus Corporation 7.6.9.1. Company overview 7.6.9.2. Financial performance 7.6.9.3. Product benchmarking 7.6.9.4. Strategic initiative 7.6.10. OTU Medical 7.6.10.1. Company overview 7.6.10.2. Financial performance 7.6.10.3. Product benchmarking 7.6.10.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD(disposable)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|